Publication | Closed Access

Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome

OncologyHepatologyLiver PhysiologySplenic VolumePathologyHepatotoxicityAcute Liver FailureUseful IndicatorLiver DiseaseLiver TransplantationMedicineProtective EffectDrug-induced Liver Injury